EE/LNG
Sponsors
AstraZeneca
Conditions
Healthy Female ParticipantsHealthy Participants
Phase 1
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
CompletedNCT05505162
Start: 2022-08-24End: 2023-01-10Updated: 2023-02-09
A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential
CompletedNCT06657105
Start: 2024-11-01End: 2025-02-03Updated: 2025-02-07
A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants
CompletedNCT06942936
Start: 2025-05-28End: 2026-01-28Updated: 2026-02-03